130 related articles for article (PubMed ID: 9232255)
1. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
[TBL] [Abstract][Full Text] [Related]
2. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
[TBL] [Abstract][Full Text] [Related]
6. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
7. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
8. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
9. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
[TBL] [Abstract][Full Text] [Related]
10. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease treated with UVB phototherapy.
Enk CD; Elad S; Vexler A; Kapelushnik J; Gorodetsky R; Kirschbaum M
Bone Marrow Transplant; 1998 Dec; 22(12):1179-83. PubMed ID: 9894721
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody analysis in chronic graft-versus-host disease.
Holmes JA; Livesey SJ; Bedwell AE; Amos N; Whittaker JA
Bone Marrow Transplant; 1989 Sep; 4(5):529-31. PubMed ID: 2790331
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
14. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
Siegert W; Stemerowicz R; Hopf U
Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
[TBL] [Abstract][Full Text] [Related]
15. Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Muro Y; Kamimoto T; Hagiwara M
Bone Marrow Transplant; 1997 May; 19(9):951-3. PubMed ID: 9156273
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies.
Kier P; Penner E; Bakos S; Kalhs P; Lechner K; Volc-Platzer B; Wesierska-Gadek J; Sauermann G; Gadner H; Emminger-Schmidmeier W
Bone Marrow Transplant; 1990 Aug; 6(2):93-6. PubMed ID: 2207457
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
Nouri-Majelan N; Sanadgol H; Ghafari A; Rahimian M; Najafi F; Mortazavizadeh M; Moghaddasi S
Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
[TBL] [Abstract][Full Text] [Related]
19. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
[TBL] [Abstract][Full Text] [Related]
20. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
Savige J; Pollock W; Trevisin M
Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
